You have 9 free searches left this month | for more free features.

Etoposide

Showing 1 - 25 of 1,852

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Cervix Carcinoma Trial in Fuzhou (Karelizumab combined with etoposide and cisplatin)

Not yet recruiting
  • Carcinoma
  • Cervix Carcinoma
  • Karelizumab combined with etoposide and cisplatin
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Jun 9, 2023

Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)

Not yet recruiting
  • Neuroendocrine Carcinoma of the Bladder
  • Bladder Cancer
  • (no location specified)
Oct 14, 2023

MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)

Not yet recruiting
  • MGMT-Unmethylated Glioblastoma
  • Etoposide Plus Cisplatin
  • (no location specified)
Jan 12, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York (Etoposide; Oral, 50 Mg, Focused

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • Etoposide; Oral, 50 Mg
  • Focused ultrasound with neuro-navigator-controlled sonication
  • New York, New York
    Columbia University Irving Medical Center
Feb 28, 2023

Merkel Cell Carcinoma Trial in Milano, Siena, Verona (Pembrolizumab, Etoposide, Cisplatin or Carboplatin)

Not yet recruiting
  • Merkel Cell Carcinoma
  • Pembrolizumab, Etoposide, Cisplatin or Carboplatin
  • Milano, Italy
  • +2 more
Oct 10, 2023

Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

Not yet recruiting
  • Autologous Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

Mammary Tumors, Human Trial in Tianjin (eutidrone etoposide bevacizumab)

Recruiting
  • Mammary Neoplasms, Human
  • eutidrone etoposide bevacizumab
  • Tianjin, Tianjin, China
    Yehui Shi
Mar 10, 2023

Small Cell Lung Cancer Extensive Stage Trial (Pembrolizumab, Plinabulin plus Etoposide and Platinum)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Pembrolizumab, Plinabulin plus Etoposide and Platinum
  • (no location specified)
Feb 15, 2023

Toripalimab, First-line Treatment Trial in Guangzhou (EP/EC+PD-1)

Recruiting
  • Toripalimab
  • First-line Treatment
  • Guangzhou, Guangdong, China
    Sun Yat-sen University cancer center
Mar 7, 2023

Germ Cell Tumor, Non-seminomatous Germ Cell Tumor, Ovarian Germ Cell Tumor Trial in Indianapolis (Etoposide)

Recruiting
  • Germ Cell Tumor
  • +2 more
  • Etoposide
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Dec 20, 2022

Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Sep 15, 2022

Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)

Recruiting
  • Lymphoma
  • BEAM Protocol
  • CEM protocol
  • Cairo, Egypt
    International Medical Center (IMC) Hospital, Cairo, Egypt.
Apr 1, 2023

Extensive Stage Small Cell Lung Cancer Trial (HLX10 + chemo (carboplatin-etoposide), Atezolizumab + chemo

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • HLX10 + chemotherapy (carboplatin-etoposide)
  • Atezolizumab + chemotherapy (carboplatin-etoposide)
  • (no location specified)
Jul 19, 2022

COVID-19 Trial in Boston (Etoposide)

Terminated
  • COVID-19
  • Etoposide
  • Boston, Massachusetts
    Boston Medical Center
Jul 1, 2022

SCLC Trial (PM8002, Platinum, Atezolizumab)

Not yet recruiting
  • SCLC
  • (no location specified)
May 4, 2023

Small Cell Lung Cancer Recurrent Trial in Madrid, Pamplona, Valencia (Debio 0123, Etoposide, Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer Recurrent
  • Debio 0123
  • +2 more
  • Madrid, Spain
  • +3 more
Apr 3, 2023

Small Cell Lung Cancer Trial in Nice (acetazolamide in combination with platinum and etoposide-based radiochemo)

Recruiting
  • Small Cell Lung Cancer
  • acetazolamide in combination with platinum and etoposide-based radiochemotherapy
  • Nice, France
    Centre Antoine Lacassagne
Jan 19, 2023

Progression Free Survival(PFS) Trial (Toposide capsules combined with anrotinib and Emvolizumab group)

Not yet recruiting
  • Progression Free Survival(PFS)
  • Toposide capsules combined with anrotinib and Emvolizumab group
  • (no location specified)
Jan 13, 2023

Determining Clinical Relevance of inTeraction Between AprepitaNt

Completed
  • Testicular Cancer
  • Blood sampling - Pharmacokinetic assessment
  • Nijmegen, Netherlands
    Radboud UMC
Sep 9, 2022

Neuroblastoma in Children Trial in Guangzhou (Tucidinostat and etoposide)

Recruiting
  • Neuroblastoma in Children
  • Tucidinostat and etoposide
  • Guangzhou, China
    Sun Yat-sen University
Jun 9, 2022

HER2-positive Breast Cancer Trial (Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab))

Not yet recruiting
  • HER2-positive Breast Cancer
  • Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab)
  • (no location specified)
Jul 20, 2023

Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)

Completed
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 14, 2022

Neuroendocrine Carcinoma Trial in Wuhan (Surufatinib and Serplulimab)

Not yet recruiting
  • Neuroendocrine Carcinoma
  • Surufatinib and Serplulimab
  • Wuhan, Hubei, China
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong
Feb 18, 2023

Brain Tumor Recurrent Trial in Houston (Methotrexate, Etoposide, Ommaya Reservoir)

Recruiting
  • Brain Tumor Recurrent
  • Houston, Texas
    UTHealth & Children's Memorial Hermann Hospital
Aug 17, 2022

Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Gainesville (Ciprofloxacin 750 MG, Etoposide,

Terminated
  • Leukemia
  • +2 more
  • Ciprofloxacin 750 MG
  • +3 more
  • Gainesville, Florida
    UF Health Shands Cancer Hospital
Jul 5, 2022